ACN
MDLZ
ABT

Nancy McKinstry

Known title: DirectorCIK: 0001294731

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Accenture caps AI tool spending at $29 per employee. Accenture has introduced a monthly spending cap of $29 for its employees using the AI tool Claude, following reports that some staff were incurring costs as high as $1,000. This move highlights the company's effort to manage expenses while integrating AI into its operations. The news comes as the stock trades near its 52-week high, reflecting ongoing investor focus on the firm's AI strategy and growth initiatives.

this person other insiders at ACN

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Mondelez Sets Q3 Earnings Date and Promotes Halloween Snacks. Mondelez International announced it will report third-quarter 2026 financial results on October 29, 2026. The company is also promoting its Sour Patch Kids brand with new Halloween-themed products and collaborations. Recent market chatter has focused on the safety of the company's dividend payout, while its stock currently trades near the top of its 52-week range.

this person other insiders at MDLZ

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Abbott Labs launches Ensure Max Protein as earnings preview approaches. Abbott Laboratories introduced a new high‑protein nutritional drink, Ensure Max Protein, expanding its consumer health lineup. At the same time, investors are looking ahead to the company's third‑quarter earnings, with analysts focusing on revenue and earnings per share estimates. TD Cowen reaffirmed its positive view of Abbott, keeping a $135 price target, which aligns with the analyst consensus range. The stock is currently near a long‑standing support level around $99.90.

this person other insiders at ABT

Transaction History

ACN▲ Buy$0
MDLZ▲ Buy$0
ACN▲ Buy$0
ABT▲ Buy$0
ACN▲ Buy$0
ACN▼ Sell$896
ACN▼ Sell$94K
ACN▲ Buy$0
ACN▲ Buy$0
ACN▲ Buy$1K
MDLZ▲ Buy$0
ACN▲ Buy$0
ABT▲ Buy$0
ACN▲ Buy$0
ACN▼ Sell$778
ACN▲ Buy$0
ACN▼ Sell$161K
ACN▲ Buy$0
ACN▲ Buy$0
ACN▲ Buy$0
ABT▲ Buy$0
ACN▲ Buy$0
ACN▼ Sell$745
ACN▼ Sell$202K
ACN▲ Buy$0
ACN▲ Buy$0
ACN▲ Buy$0
ACN▲ Buy$0
ABT▲ Buy$0
ABT▲ Buy$0
ABT▼ Sell$188K
ABT▲ Buy$187K

We use analytics to understand how market-wall is used. No personal data is sold.